The novel selective antibody sibeprenlimab reduced proteinuria more than any prior drug for IgA nephropathy, with excellent ...

A subanalysis of the NeflgArd study shows benefits in eGFR and urine protein-creatinine ratio at baseline and across ...

A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...

Wastewater monitoring helps communities spot rising outbreaks of influenza, COVID, RSV, and more. Our writer gets her feet ...

MRI visibility and the presence of secondary Gleason pattern 4 at baseline are associated with progression to treatment and ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

Music has shown promise in easing symptoms of neurodegenerative disease — but don’t expect a prescribed playlist anytime soon ...

Adjunctive D-serine fails to outperform placebo in major depressive disorder but offers benefit in severe cases, especially ...

Significant support and follow-up’ may be necessary for older patients to implement their care plans, according to a ...

But new research published in JAMA Pediatrics found distinct patterns of long COVID symptoms in young children. Researchers ...

Low-dose methotrexate for 1 year does not reduce knee pain or effusion-synovitis in patients with inflammatory knee ...

Obefazimod shows efficacy and favourable safety in patients with moderate to severely active ulcerative colitis in a 96-week ...